Brought to you by

Novartis buys CoStim Pharmaceuticals
18 Sep 2020
Executive Summary
Novartis AG acquired CoStim Phamaceuticals Inc., a closely held firm that has been working on immune-based cancer therapeutics.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement